Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1749 studies found for:    (psychotic disorders OR schizophrenia) AND (woman OR women OR female)
Show Display Options
RSS Create an RSS feed from your search for:
(psychotic disorders OR schizophrenia) AND (woman OR women OR female)
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women
Condition: Negative Symptoms of Schizophrenia in Post-menopausal Women.
Interventions: Drug: Raloxifene;   Drug: Lactosa (placebo arm)
2 Recruiting Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: Raloxifene hydrochloride;   Drug: Placebo
3 Completed Clinical Estradiol Trial in Women With Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder
Intervention: Drug: Estradiol
4 Completed Double Blind, Placebo-controlled Study of Raloxifene for Negative Symptoms of Schizophrenia in Postmenopausal Women
Condition: Schizophrenia
Intervention: Drug: raloxifene
5 Completed Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: SEP-363856;   Drug: Placebo;   Drug: SEP-363856 Open Label
6 Completed A Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: SEP-363856;   Drug: Placebo
7 Completed
Has Results
Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia
Conditions: Obesity;   Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: Naltrexone 25mg;   Other: Placebo
8 Completed Gender Differences in Social Cognition in Patients With Schizophrenia of Recent Diagnosis and Healthy Controls Subjects
Conditions: Women With Recent Diagnosis of Schizophrenia;   Men With Recent Diagnosis of Schizophrenia;   Healthy Women;   Healthy Men
Intervention: Other: GENDER
9 Terminated Quality of Life (QOL) in Female Patient With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Quetiapine, Risperidone
10 Recruiting Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia
Condition: Hyperprolactinemia
Interventions: Drug: Aripiprazole;   Drug: Placebo
11 Recruiting Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: Lu AF35700 (10 mg/day);   Drug: Lu AF35700 (30 mg/day);   Drug: Quetiapine (Seroquel XR® 800 mg/day)
12 Completed Homeopathic Medication and Nutritional Oriented Diet to Treat Overweight Pregnant Women With Mental Disorder
Conditions: Overweight;   Pregnancy;   Mental Disorder
Interventions: Drug: Sulph, Puls, Lyc, Lack t, Con, Sep, Nux v, Calc c, Phos;   Drug: Homeopathy and Nutritional oriented diet
13 Completed
Has Results
A Definitive Estrogen Patch Study (ADEPT)
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder(Not in Manic Phase)
Interventions: Drug: Estradiol;   Other: placebo
14 Completed Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics
Condition: Schizophrenia
Interventions: Drug: SEP-363856;   Drug: Amisulpride;   Drug: Placebo
15 Completed Clinical Study Of Schizophrenia in Both Men and Women
Condition: Schizophrenia
Intervention: Drug: lamotrigine
16 Completed Pharmacokinetics, Effect of Food, Safety and Tolerability of a New Tablet Formulation of GSK1144814 in Healthy Subjects
Condition: Schizophrenia
Intervention: Drug: GSK1144814
17 Completed Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female Subjects
Condition: Schizophrenia
Intervention: Drug: SCA-136
18 Completed Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness
Conditions: Schizophrenia;   Bipolar Disorder;   Schizoaffective Disorder
Intervention: Behavioral: Genetic Counseling
19 Completed A Pharmacokinetics Study to Evaluate Safety and Tolerability of JNJ-37822681 in Participants With Stable Schizophrenia
Condition: Schizophrenia
Interventions: Drug: JNJ-37822681;   Other: Placebo
20 Withdrawn Behavioral Health Services for Women Receiving Public Assistance
Condition: Mental Disorders
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.